SCHEMBL7736987

SCHEMBL7736987

[CH2]c1cccc2[nH]nc(N)c12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 4/20 0.61
GAA P10253 2/20 0.61
MAP2K1 Q02750 2/20 0.56
KDR P35968 9/20 0.54
KIT P10721 7/20 0.54
FLT3 P36888 6/20 0.54
ROCK1 Q13464 4/20 0.51
JAK2 O60674 4/20 0.51
LCK P06239 3/20 0.51
CSF1R P07333 3/20 0.51
FGFR1 P11362 3/20 0.51
PRKACA P17612 3/20 0.51
CDK5 Q00535 3/20 0.51
CLK4 Q9HAZ1 2/20 0.51
PLK4 O00444 2/20 0.51
AURKA O14965 2/20 0.51
CDK1 P06493 2/20 0.51
LYN P07948 2/20 0.51
SRC P12931 2/20 0.51
RPS6KB1 P23443 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628649 0.79 PDPK1 (0.66) PDPK1GAAMAP2K1KDRKIT
SCHEMBL30065304 0.79 PDPK1 (0.66) PDPK1GAAMAP2K1KDRKIT
SCHEMBL569660 0.76 GAA (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL186280 0.76 GAA (1.00) PDPK1GAAMAP2K1KDRKIT
SCHEMBL30248298 0.76 GAA (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL185907 0.76 GAA (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL12928484 0.76 PDPK1 (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL10368038 0.76 PDPK1 (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL760018 0.76 PDPK1 (0.61) PDPK1GAAMAP2K1KDRKIT
SCHEMBL30566149 0.76 PDPK1 (0.61) PDPK1GAAMAP2K1KDRKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37781-E1 VIRICIDES, PROTEASE INHIBITOR DUPONT PHARMACEUTICALS COMPANY 2002-07-02 US claimed
US-5877170-A VIRICIDES DUPONT PHARMACEUTICALS COMPANY (US) 1999-03-02 US claimed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US claimed